BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Imai Y, Murakami T, Yoshida S, Nishikawa M, Ohsawa M, Tokunaga K, Murata M, Shibata K, Zushi S, Kurokawa M. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology. 2000;32:205-212. [PMID: 10915725 DOI: 10.1053/jhep.2000.9113] [Cited by in Crossref: 161] [Cited by in F6Publishing: 140] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Tanimoto A, Min Lee J, Murakami T, Huppertz A, Kudo M, Grazioli L. Consensus report of the 2nd International Forum for Liver MRI. Eur Radiol 2009;19:975-89. [DOI: 10.1007/s00330-009-1624-y] [Cited by in Crossref: 84] [Cited by in F6Publishing: 76] [Article Influence: 6.5] [Reference Citation Analysis]
2 Arita J, Takahashi M, Hata S, Shindoh J, Beck Y, Sugawara Y, Hasegawa K, Kokudo N. Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma. Ann Surg. 2011;254:992-999. [PMID: 21694582 DOI: 10.1097/SLA.0b013e31822518be] [Cited by in Crossref: 43] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
3 Tanaka H. Current role of ultrasound in the diagnosis of hepatocellular carcinoma. J Med Ultrason (2001) 2020;47:239-55. [PMID: 32170489 DOI: 10.1007/s10396-020-01012-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
4 Inoue T, Kudo M, Watai R, Pei Z, Kawasaki T, Minami Y, Chung H, Fukunaga T, Awai K, Maenishi O. Differential diagnosis of nodular lesions in cirrhotic liver by post-vascular phase contrast-enhanced US with Levovist: comparison with superparamagnetic iron oxide magnetic resonance images. J Gastroenterol. 2005;40:1139-1147. [PMID: 16378178 DOI: 10.1007/s00535-005-1712-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
5 Rosen JE, Chan L, Shieh D, Gu FX. Iron oxide nanoparticles for targeted cancer imaging and diagnostics. Nanomedicine: Nanotechnology, Biology and Medicine 2012;8:275-90. [DOI: 10.1016/j.nano.2011.08.017] [Cited by in Crossref: 213] [Cited by in F6Publishing: 172] [Article Influence: 21.3] [Reference Citation Analysis]
6 Yoon MA, Kim SH, Park HS, Lee DH, Lee JY, Han JK, Choi BI. Value of Dual Contrast Liver MRI at 3.0 T in Differentiating Well-Differentiated Hepatocellular Carcinomas From Dysplastic Nodules: Preliminary Results of Multivariate Analysis. Investigative Radiology 2009;44:641-9. [DOI: 10.1097/rli.0b013e3181ab6e57] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
7 Korenaga K, Korenaga M, Furukawa M, Yamasaki T, Sakaida I. Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images. J Gastroenterol 2009;44:733-41. [PMID: 19387532 DOI: 10.1007/s00535-009-0053-7] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 4.8] [Reference Citation Analysis]
8 Wang YX. Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application. Quant Imaging Med Surg 2011;1:35-40. [PMID: 23256052 DOI: 10.3978/j.issn.2223-4292.2011.08.03] [Cited by in F6Publishing: 226] [Reference Citation Analysis]
9 Sano K, Ichikawa T, Motosugi U, Sou H, Muhi AM, Matsuda M, Nakano M, Sakamoto M, Nakazawa T, Asakawa M, Fujii H, Kitamura T, Enomoto N, Araki T. Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging. Radiology. 2011;261:834-844. [PMID: 21998047 DOI: 10.1148/radiol.11101840] [Cited by in Crossref: 221] [Cited by in F6Publishing: 206] [Article Influence: 20.1] [Reference Citation Analysis]
10 Hussain SM, Reinhold C, Mitchell DG. Cirrhosis and lesion characterization at MR imaging. Radiographics. 2009;29:1637-1652. [PMID: 19959512 DOI: 10.1148/rg.296095508] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
11 Lin KY, Kwong GA, Warren AD, Wood DK, Bhatia SN. Nanoparticles that sense thrombin activity as synthetic urinary biomarkers of thrombosis. ACS Nano. 2013;7:9001-9009. [PMID: 24015809 DOI: 10.1021/nn403550c] [Cited by in Crossref: 68] [Cited by in F6Publishing: 58] [Article Influence: 7.6] [Reference Citation Analysis]
12 Chou CT, Chen RC, Chen WT, Lii JM. Detection of hepatocellular carcinoma by ferucarbotran-enhanced magnetic resonance imaging: the efficacy of accumulation phase fat-suppressed T1-weighted imaging. Clin Radiol 2009;64:22-9. [PMID: 19070694 DOI: 10.1016/j.crad.2008.07.010] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
13 Makino Y, Imai Y, Ohama H, Igura T, Kogita S, Sawai Y, Fukuda K, Takamura M, Ohashi H, Murakami T. Ultrasonography Fusion Imaging System Increases the Chance of Radiofrequency Ablation for Hepatocellular Carcinoma with Poor Conspicuity on Conventional Ultrasonography. Oncology 2013;84:44-50. [DOI: 10.1159/000345889] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
14 Murakami T, Imai Y, Okada M, Hyodo T, Lee WJ, Kim MJ, Kim T, Choi BI. Ultrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: toward improved treatment decisions. Oncology. 2011;81 Suppl 1:86-99. [PMID: 22212941 DOI: 10.1159/000333267] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
15 Martin DR, Semelka RC. Magnetic Resonance Imaging of the Liver: Review of Techniques and Approach to Common Diseases. Seminars in Ultrasound, CT and MRI 2005;26:116-31. [DOI: 10.1053/j.sult.2005.02.009] [Cited by in Crossref: 34] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
16 Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, Shiina S, Cheng AL, Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chawla YK, Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF, Sarin SK. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010;4:439-74. [PMID: 20827404 DOI: 10.1007/s12072-010-9165-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Kairdolf BA, Qian X, Nie S. Bioconjugated Nanoparticles for Biosensing, in Vivo Imaging, and Medical Diagnostics. Anal Chem 2017;89:1015-31. [DOI: 10.1021/acs.analchem.6b04873] [Cited by in Crossref: 94] [Cited by in F6Publishing: 74] [Article Influence: 18.8] [Reference Citation Analysis]
18 Motosugi U, Bannas P, Sano K, Reeder SB. Hepatobiliary MR contrast agents in hypovascular hepatocellular carcinoma. J Magn Reson Imaging 2015;41:251-65. [PMID: 25104398 DOI: 10.1002/jmri.24712] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
19 Kaplan DE, Reddy KR. Rising incidence of hepatocellular carcinoma: the role of hepatitis B and C; the impact on transplantation and outcomes. Clin Liver Dis 2003;7:683-714. [PMID: 14509534 DOI: 10.1016/s1089-3261(03)00060-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
20 Liu K, He X, Lei XZ, Zhao LS, Tang H, Liu L, Lei BJ. Pathomorphological study on location and distribution of Kupffer cells in hepatocellular carcinoma. World J Gastroenterol 2003; 9(9): 1946-1949 [PMID: 12970881 DOI: 10.3748/wjg.v9.i9.1946] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 38] [Article Influence: 2.2] [Reference Citation Analysis]
21 Maruyama H, Yoshikawa M, Yokosuka O. Current role of ultrasound for the management of hepatocellular carcinoma. World J Gastroenterol 2008; 14(11): 1710-1719 [PMID: 18350602 DOI: 10.3748/wjg.14.1710] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
22 Frericks BB, Loddenkemper C, Huppertz A, Valdeig S, Stroux A, Seja M, Wolf K, Albrecht T. Qualitative and Quantitative Evaluation of Hepatocellular Carcinoma and Cirrhotic Liver Enhancement Using Gd-EOB-DTPA. American Journal of Roentgenology 2009;193:1053-60. [DOI: 10.2214/ajr.08.1946] [Cited by in Crossref: 120] [Cited by in F6Publishing: 42] [Article Influence: 9.2] [Reference Citation Analysis]
23 Kamel IR, Bluemke DA. Imaging Evaluation of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2002;13:S173-83. [DOI: 10.1016/s1051-0443(07)61784-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
24 Qi Y, Li W, Fang J, Xiang Y, Zhu M, Zhang X, Ma X, Wang Q, Zhan J, Yu D. Application and mechanism of manganese-coated caramelization nanospheres for active targeting in hepatobiliary tumors. Nanomedicine (Lond) 2019;14:2973-85. [PMID: 31793384 DOI: 10.2217/nnm-2018-0272] [Reference Citation Analysis]
25 Inoue T, Kudo M, Komuta M, Hayaishi S, Ueda T, Takita M, Kitai S, Hatanaka K, Yada N, Hagiwara S, Chung H, Sakurai T, Ueshima K, Sakamoto M, Maenishi O, Hyodo T, Okada M, Kumano S, Murakami T. Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT. J Gastroenterol 2012;47:1036-47. [DOI: 10.1007/s00535-012-0571-6] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 5.7] [Reference Citation Analysis]
26 Yang WY, Park HS, Kim YJ, Yu MH, Jung SI, Jeon HJ. Visibility of focal liver lesions: Comparison between kupffer phase of CEUS with sonazoid and hepatobiliary phase of gadoxetic acid-enhanced MRI. J Clin Ultrasound 2017;45:542-50. [PMID: 28547764 DOI: 10.1002/jcu.22499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
27 Ishigami K, Tajima T, Fujita N, Nishie A, Asayama Y, Kakihara D, Nakayama T, Okamoto D, Taketomi A, Shirabe K, Honda H. Hepatocellular carcinoma with marginal superparamagnetic iron oxide uptake on T2*-weighted magnetic resonance imaging: histopathologic correlation. Eur J Radiol 2011;80:e293-8. [PMID: 21288675 DOI: 10.1016/j.ejrad.2010.12.078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
28 Sugimoto K, Moriyasu F, Saito K, Taira J, Saguchi T, Yoshimura N, Oshiro H, Imai Y, Shiraishi J. Comparison of Kupffer-phase Sonazoid-enhanced sonography and hepatobiliary-phase gadoxetic acid-enhanced magnetic resonance imaging of hepatocellular carcinoma and correlation with histologic grading. J Ultrasound Med 2012;31:529-38. [PMID: 22441909 DOI: 10.7863/jum.2012.31.4.529] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
29 Liu T, Choi H, Zhou R, Chen IW. Quantitative evaluation of the reticuloendothelial system function with dynamic MRI. PLoS One 2014;9:e103576. [PMID: 25090653 DOI: 10.1371/journal.pone.0103576] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
30 Maruyama H, Takahashi M, Ishibashi H, Okabe S, Yoshikawa M, Yokosuka O. Changes in tumor vascularity precede microbubble contrast accumulation deficit in the process of dedifferentiation of hepatocellular carcinoma. Eur J Radiol 2010;75:e102-6. [PMID: 19783392 DOI: 10.1016/j.ejrad.2009.08.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
31 Fujishiro YI, Koie H, Nakayama S, Shibata H, Okabayashi S, Katakai Y, Kanayama K, Yasutomi Y, Ageyama N. Superparamagnetic Iron Oxide-enhanced Magnetic Resonance Imaging of Spontaneous Hepatic Neoplasia in a Cynomolgus Macaque (Macaca fascicularis). Comp Med 2018;68:233-8. [PMID: 29843863 DOI: 10.30802/AALAS-CM-17-000063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Kudo M. Diagnostic imaging of hepatocellular carcinoma: Recent progress. Oncology. 2011;81 Suppl 1:73-85. [PMID: 22212940 DOI: 10.1159/000333265] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 4.5] [Reference Citation Analysis]
33 Hanna RF, Aguirre DA, Kased N, Emery SC, Peterson MR, Sirlin CB. Cirrhosis-associated Hepatocellular Nodules: Correlation of Histopathologic and MR Imaging Features. RadioGraphics 2008;28:747-69. [DOI: 10.1148/rg.283055108] [Cited by in Crossref: 130] [Cited by in F6Publishing: 93] [Article Influence: 9.3] [Reference Citation Analysis]
34 Murata K, Saito A, Katagiri S, Ariizumi S, Nakano M, Yamamoto M. Association of des-γ-carboxy prothrombin production and Sonazoid-enhanced ultrasound findings in hepatocellular carcinomas of different histologic grades. J Med Ultrason (2001) 2018;45:223-9. [PMID: 28828695 DOI: 10.1007/s10396-017-0816-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
35 Nishie A, Tajima T, Asayama Y, Ishigami K, Kakihara D, Nakayama T, Takayama Y, Okamoto D, Fujita N, Taketomi A. Diagnostic performance of apparent diffusion coefficient for predicting histological grade of hepatocellular carcinoma. Eur J Radiol. 2011;80:e29-e33. [PMID: 20619566 DOI: 10.1016/j.ejrad.2010.06.019] [Cited by in Crossref: 86] [Cited by in F6Publishing: 86] [Article Influence: 7.2] [Reference Citation Analysis]
36 Nishie A, Asayama Y, Ishigami K, Tajima T, Kakihara D, Nakayama T, Takayama Y, Okamoto D, Taketomi A, Shirabe K. MR prediction of liver fibrosis using a liver-specific contrast agent: Superparamagnetic iron oxide versus Gd-EOB-DTPA. J Magn Reson Imaging. 2012;36:664-671. [PMID: 22532503 DOI: 10.1002/jmri.23691] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 5.7] [Reference Citation Analysis]
37 Makino Y, Imai Y, Igura T, Hori M, Fukuda K, Sawai Y, Kogita S, Ohama H, Matsumoto Y, Nakahara M, Zushi S, Kurokawa M, Isotani K, Takamura M, Fujita N, Murakami T. Utility of computed tomography fusion imaging for the evaluation of the ablative margin of radiofrequency ablation for hepatocellular carcinoma and the correlation to local tumor progression: Evaluation of RFA using CT fusion image. Hepatol Res 2013;43:950-8. [DOI: 10.1111/hepr.12049] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
38 Kogita S, Imai Y, Okada M, Kim T, Onishi H, Takamura M, Fukuda K, Igura T, Sawai Y, Morimoto O, Hori M, Nagano H, Wakasa K, Hayashi N, Murakami T. Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow. Eur Radiol 2010;20:2405-13. [PMID: 20490505 DOI: 10.1007/s00330-010-1812-9] [Cited by in Crossref: 176] [Cited by in F6Publishing: 158] [Article Influence: 14.7] [Reference Citation Analysis]
39 Park HS, Lee JM, Kim SH, Chang S, Kim SJ, Han JK, Choi BI. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla. J Magn Reson Imaging. 2009;29:328-335. [PMID: 19161184 DOI: 10.1002/jmri.21615] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
40 Mori Y, Tamai H, Shingaki N, Moribata K, Shiraki T, Deguchi H, Ueda K, Enomoto S, Magari H, Inoue I. Diffuse intrahepatic recurrence after percutaneous radiofrequency ablation for solitary and small hepatocellular carcinoma. Hepatol Int. 2009;3:509-515. [PMID: 19669252 DOI: 10.1007/s12072-009-9131-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
41 Ruilong Z, Daohai X, Li G, Xiaohong W, Chunjie W, Lei T. Diagnostic value of 18F-FDG-PET/CT for the evaluation of solitary pulmonary nodules: a systematic review and meta-analysis. Nuclear Medicine Communications 2017;38:67-75. [DOI: 10.1097/mnm.0000000000000605] [Cited by in Crossref: 38] [Cited by in F6Publishing: 18] [Article Influence: 7.6] [Reference Citation Analysis]
42 Yoneda N, Matsui O, Kobayashi S, Kitao A, Kozaka K, Inoue D, Yoshida K, Minami T, Koda W, Gabata T. Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma. Jpn J Radiol. 2019;37:191-208. [PMID: 30712167 DOI: 10.1007/s11604-019-00817-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
43 Golfieri R, Marini E, Bazzocchi A, Fusco F, Trevisani F, Sama C, Mazzella G, Cavuto S, Piscaglia F, Bolondi L. Small (<or=3 cm) hepatocellular carcinoma in cirrhosis: the role of double contrast agents in MR imaging vs. multidetector-row CT. Radiol Med. 2009;114:1239-1266. [PMID: 19697104 DOI: 10.1007/s11547-009-0439-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
44 Onishi H, Murakami T, Nakamura H. Diagnosis of Hepatocellular Carcinoma: Multidetector-Row Computed Tomography and Magnetic Resonance Imaging. In: Hayat MA, editor. Liver Cancer. Dordrecht: Springer Netherlands; 2009. pp. 221-35. [DOI: 10.1007/978-1-4020-9804-8_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
45 Goto E, Masuzaki R, Tateishi R, Kondo Y, Imamura J, Goto T, Ikeda H, Akahane M, Shiina S, Omata M, Yoshida H, Koike K. Value of post-vascular phase (Kupffer imaging) by contrast-enhanced ultrasonography using Sonazoid in the detection of hepatocellular carcinoma. J Gastroenterol 2012;47:477-85. [PMID: 22200940 DOI: 10.1007/s00535-011-0512-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
46 Li YW, Chen ZG, Wang JC, Zhang ZM. Superparamagnetic iron oxide-enhanced magnetic resonance imaging for focal hepatic lesions: Systematic review and meta-analysis. World J Gastroenterol 2015; 21(14): 4334-4344 [PMID: 25892885 DOI: 10.3748/wjg.v21.i14.4334] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
47 Park YN, Kim MJ. Hepatocarcinogenesis: imaging-pathologic correlation. Abdom Imaging. 2011;36:232-243. [PMID: 21267560 DOI: 10.1007/s00261-011-9688-y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
48 Kim MJ, Kim JH, Lim JS, Oh YT, Chung JJ, Choi JS, Lee WJ, Kim KW. Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging. J Magn Reson Imaging 2004;20:612-21. [PMID: 15390224 DOI: 10.1002/jmri.20174] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
49 Matsui O, Gabata T, Kobayashi S. Optimal imaging of hepatic mass lesions. J Gastroenterol Hepatol 2008;23:1466-8. [PMID: 19120844 DOI: 10.1111/j.1440-1746.2008.05647.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
50 Nishie A, Ushijima Y, Tajima T, Asayama Y, Ishigami K, Kakihara D, Nakayama T, Takayama Y, Okamoto D, Abe K, Obara M, Yoshimitsu K, Honda H. Quantitative analysis of liver function using superparamagnetic iron oxide- and Gd-EOB-DTPA-enhanced MRI: comparison with Technetium-99m galactosyl serum albumin scintigraphy. Eur J Radiol 2012;81:1100-4. [PMID: 21435811 DOI: 10.1016/j.ejrad.2011.02.053] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
51 Chanyaputhipong J, Low SC, Chow PK. Gadoxetate Acid-Enhanced MR Imaging for HCC: A Review for Clinicians. Int J Hepatol. 2011;2011:489342. [PMID: 21994860 DOI: 10.4061/2011/489342] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
52 Sakabe K, Yamamoto T, Kubo S, Hirohashi K, Hamuro M, Nakamura K, Inoue Y, Kaneda K, Suehiro S. Correlation between dynamic computed tomographic and histopathological findings in the diagnosis of small hepatocellular carcinoma. Dig Surg 2004;21:413-20. [PMID: 15564787 DOI: 10.1159/000082318] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
53 Schneider G, Grazioli L, Saini S. Techniques for Liver MR Imaging. In: Schneider G, Grazioli L, Saini S, editors. MRI of the Liver. Milano: Springer Milan; 2006. pp. 1-16. [DOI: 10.1007/88-470-0469-1_1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
54 Zech CJ, Reiser MF. Radiological Evaluation of Patients with Liver Tumors. In: Bilbao JI, Reiser MF, editors. Liver Radioembolization with 90Y Microspheres. Berlin: Springer Berlin Heidelberg; 2008. pp. 15-28. [DOI: 10.1007/978-3-540-35423-9_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
55 Yang DJ, Azhdarinia A, Wu P, Yu DF, Tansey W, Kalimi SK, Kim EE, Podoloff DA. In vivo and in vitro measurement of apoptosis in breast cancer cells using 99mTc-EC-annexin V. Cancer Biother Radiopharm 2001;16:73-83. [PMID: 11279800 DOI: 10.1089/108497801750096087] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 2.2] [Reference Citation Analysis]
56 Chung J, Yu JS, Kim DJ, Chung JJ, Kim JH, Kim KW. Hypervascular hepatocellular carcinoma in the cirrhotic liver: diffusion-weighted imaging versus superparamagnetic iron oxide-enhanced MRI. Magn Reson Imaging 2011;29:1235-43. [PMID: 21907517 DOI: 10.1016/j.mri.2011.07.025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
57 Hori M, Murakami T, Kim T, Tsuda K, Takahashi S, Okada A, Takamura M, Nakamura H. Detection of Hypervascular Hepatocellular Carcinoma: Comparison of SPIO-enhanced MRI With Dynamic Helical CT: . Journal of Computer Assisted Tomography 2002;26:701-10. [DOI: 10.1097/00004728-200209000-00007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
58 Yoshida H, Yoshida H, Shiina S, Omata M. Early liver cancer: concepts, diagnosis, and management. Int J Clin Oncol 2005;10:384-90. [DOI: 10.1007/s10147-005-0537-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
59 Wang F, Numata K, Nakano M, Tanabe M, Chuma M, Nihonmatsu H, Nozaki A, Ogushi K, Luo W, Ruan L, Okada M, Otani M, Inayama Y, Maeda S. Diagnostic Value of Imaging Methods in the Histological Four Grading of Hepatocellular Carcinoma. Diagnostics (Basel) 2020;10:E321. [PMID: 32438701 DOI: 10.3390/diagnostics10050321] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
60 Kim SH, Lee WJ, Lim HK, Park CK. SPIO-enhanced MRI findings of well-differentiated hepatocellular carcinomas: correlation with MDCT findings. Korean J Radiol 2009;10:112-20. [PMID: 19270856 DOI: 10.3348/kjr.2009.10.2.112] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
61 Maruyama H, Takahashi M, Ishibashi H, Yoshikawa M, Yokosuka O. Contrast-enhanced ultrasound for characterisation of hepatic lesions appearing non-hypervascular on CT in chronic liver diseases. Br J Radiol. 2012;85:351-357. [PMID: 21224305 DOI: 10.1259/bjr/20440141] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
62 Yoo HJ, Lee JM, Lee JY, Kim SH, Kim SJ, Han JK, Choi BI. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver. Invest Radiol. 2009;44:800-807. [PMID: 19838119 DOI: 10.1097/rli.0b013e3181bc271d] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
63 Tonan T, Fujimoto K, Azuma S, Ono N, Matsushita S, Kojiro M, Hayabuchi N. Evaluation of small (<or=2 cm) dysplastic nodules and well-differentiated hepatocellular carcinomas with ferucarbotran-enhanced MRI in a 1.0-T MRI unit: utility of T2*-weighted gradient echo sequences with an intermediate-echo time. Eur J Radiol 2007;64:133-9. [PMID: 17408900 DOI: 10.1016/j.ejrad.2007.02.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
64 Ogawa S, Kumada T, Toyoda H, Ichikawa H, Kawachi T, Otobe K, Hibi T, Takeshima K, Kiriyama S, Sone Y. Evaluation of pathological features of hepatocellular carcinoma by contrast-enhanced ultrasonography: comparison with pathology on resected specimen. Eur J Radiol. 2006;59:74-81. [PMID: 16545532 DOI: 10.1016/j.ejrad.2006.02.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
65 Ohama H, Imai Y, Nakashima O, Kogita S, Takamura M, Hori M, Seki Y, Sawai Y, Igura T, Fukuda K. Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI. J Gastroenterol. 2014;49:1081-1093. [PMID: 23903870 DOI: 10.1007/s00535-013-0859-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
66 Sommer WH, Sourbron S, Huppertz A, Ingrisch M, Reiser MF, Zech CJ. Contrast agents as a biological marker in magnetic resonance imaging of the liver: conventional and new approaches. Abdom Imaging. 2012;37:164-179. [PMID: 21516381 DOI: 10.1007/s00261-011-9734-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
67 Tsuboyama T, Onishi H, Kim T, Akita H, Hori M, Tatsumi M, Nakamoto A, Nagano H, Matsuura N, Wakasa K, Tomoda K. Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation. Radiology. 2010;255:824-833. [PMID: 20501720 DOI: 10.1148/radiol.10091557] [Cited by in Crossref: 179] [Cited by in F6Publishing: 173] [Article Influence: 14.9] [Reference Citation Analysis]
68 Imai Y, Murakami T, Hori M, Fukuda K, Kim T, Marukawa T, Abe H, Kuwabara M, Onishi H, Tsuda K, Sawai Y, Kurokawa M, Hayashi N, Monden M, Nakamura H. Hypervascular hepatocellular carcinoma: Combined dynamic MDCT and SPIO-enhanced MRI versus combined CTHA and CTAP. Hepatol Res 2008;38:147-58. [PMID: 17645518 DOI: 10.1111/j.1872-034X.2007.00210.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
69 Dahmarde H, Parooie F, Salarzaei M. Is 18F-FDG PET/CT an Accurate Way to Detect Lymph Node Metastasis in Colorectal Cancer: A Systematic Review and Meta-Analysis. Contrast Media Mol Imaging 2020;2020:5439378. [PMID: 32733174 DOI: 10.1155/2020/5439378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
70 Tanimoto A, Kuribayashi S. Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma. Eur J Radiol 2006;58:200-16. [PMID: 16414230 DOI: 10.1016/j.ejrad.2005.11.040] [Cited by in Crossref: 100] [Cited by in F6Publishing: 83] [Article Influence: 6.3] [Reference Citation Analysis]
71 Kim MJ, Kim JH, Choi JY, Park SH, Chung JJ, Kim KW, Mitchell DG. Optimal TE for SPIO-enhanced gradient-recalled echo MRI for the detection of focal hepatic lesions. AJR Am J Roentgenol 2006;187:W255-66. [PMID: 16928903 DOI: 10.2214/AJR.05.0706] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
72 Suzuki M, Maeyama S, Takahashi H, Okuse N, Takahashi Y, Mizuno H, Yotuyanagi H, Suzuki H, Itoh F, Uchikoshi T. Strategy for Hepatic Hyperplastic Nodules in Heavy Drinkers. Alcoholism Clin Exp Res 2004;28:153S-8S. [DOI: 10.1111/j.1530-0277.2004.tb03235.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
73 Kudo M, Kawamura Y, Hasegawa K, Tateishi R, Kariyama K, Shiina S, Toyoda H, Imai Y, Hiraoka A, Ikeda M, Izumi N, Moriguchi M, Ogasawara S, Minami Y, Ueshima K, Murakami T, Miyayama S, Nakashima O, Yano H, Sakamoto M, Hatano E, Shimada M, Kokudo N, Mochida S, Takehara T. Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update. Liver Cancer 2021;10:181-223. [PMID: 34239808 DOI: 10.1159/000514174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Arnold P, Ward J, Wilson D, Ashley Guthrie J, Robinson PJ. Superparamagnetic iron oxide (SPIO) enhancement in the cirrhotic liver: a comparison of two doses of ferumoxides in patients with advanced disease. Magnetic Resonance Imaging 2003;21:695-700. [DOI: 10.1016/s0730-725x(03)00101-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
75 Imai K, Beppu T, Nakayama Y, Ishiko T, Horino K, Komori H, Masuda T, Hayashi H, Okabe H, Baba Y, Watanabe M, Takamori H, Awai K, Yamashita Y, Baba H. Preoperative prediction of poorly differentiated components in small-sized hepatocellular carcinoma for safe local ablation therapy. J Surg Oncol 2009;100:121-6. [PMID: 19402077 DOI: 10.1002/jso.21302] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
76 Burrel M, Llovet JM, Ayuso C, Iglesias C, Sala M, Miquel R, Caralt T, Ayuso JR, Solé M, Sanchez M. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology. 2003;38:1034-1042. [PMID: 14512891 DOI: 10.1002/hep.1840380430] [Cited by in Crossref: 297] [Cited by in F6Publishing: 162] [Article Influence: 15.6] [Reference Citation Analysis]
77 Liang PC, Chen YC, Chiang CF, Mo LR, Wei SY, Hsieh WY, Lin WL. Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance imaging-monitoring magnet-enhancing tumor chemotherapy. Int J Nanomedicine 2016;11:2021-37. [PMID: 27274233 DOI: 10.2147/IJN.S94139] [Cited by in Crossref: 11] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
78 Schneider G, Grazioli L, Saini S. Imaging of Malignant Focal Liver Lesions. In: Schneider G, Grazioli L, Saini S, editors. MRI of the Liver. Milano: Springer Milan; 2006. pp. 187-235. [DOI: 10.1007/88-470-0469-1_6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
79 Koda M, Tokunaga S, Okamoto T, Hodozuka M, Miyoshi K, Kishina M, Fujise Y, Kato J, Matono T, Sugihara T. Clinical usefulness of the ablative margin assessed by magnetic resonance imaging with Gd-EOB-DTPA for radiofrequency ablation of hepatocellular carcinoma. J Hepatol. 2015;63:1360-1367. [PMID: 26232269 DOI: 10.1016/j.jhep.2015.07.023] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
80 Yoshizumi H, Maruyama H, Okugawa H, Kobayashi S, Akiike T, Yoshikawa M, Ebara M, Yokosuka O, Matsutani S, Kondo F, Kamiyama N. How to characterize non-hypervascular hepatic nodules on contrast-enhanced computed tomography in chronic liver disease: Feasibility of contrast-enhanced ultrasound with a microbubble contrast agent. Journal of Gastroenterology and Hepatology 2008;23:1528-34. [DOI: 10.1111/j.1440-1746.2007.05184.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
81 Zhang C, Yan Y, Zou Q, Chen J, Li C. Superparamagnetic iron oxide nanoparticles for MR imaging of pancreatic cancer: Potential for early diagnosis through targeted strategies: SPION for MRI of pancreatic cancer. Asia-Pac J Clin Oncol 2016;12:13-21. [DOI: 10.1111/ajco.12437] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
82 Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, Shiina S, Cheng AL, Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chawla YK, Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF, Sarin SK. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int. 2010;4:439-474. [PMID: 20827404 DOI: 10.1007/s12072-010-9165-7] [Cited by in Crossref: 684] [Cited by in F6Publishing: 685] [Article Influence: 57.0] [Reference Citation Analysis]
83 Hong HS, Byun JH, Won HJ, Kim KW, Lee SS, Lee MG, Yun SC. Characterization of liver metastases: the efficacy of biphasic magnetic resonance imaging with ferucarbotran-enhancement. Clin Radiol 2010;65:701-7. [PMID: 20696297 DOI: 10.1016/j.crad.2010.04.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
84 Martin DR, Danrad R, Hussain SM. MR imaging of the liver. Radiol Clin North Am 2005;43:861-86, viii. [PMID: 16098344 DOI: 10.1016/j.rcl.2005.05.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
85 Taouli B, Losada M, Holland A, Krinsky G. Magnetic resonance imaging of hepatocellular carcinoma. Gastroenterology. 2004;127:S144-S152. [PMID: 15508078 DOI: 10.1053/j.gastro.2004.09.028] [Cited by in Crossref: 68] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
86 Tanaka H, Iijima H, Higashiura A, Yoh K, Ishii A, Takashima T, Sakai Y, Aizawa N, Iwata K, Ikeda N, Iwata Y, Enomoto H, Saito M, Imanishi H, Hirota S, Fujimoto J, Nishiguchi S. New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography. J Gastroenterol 2014;49:755-63. [DOI: 10.1007/s00535-013-0830-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
87 Hanna RF, Kased N, Kwan SW, Gamst AC, Santosa AC, Hassanein T, Sirlin CB. Double-contrast MRI for accurate staging of hepatocellular carcinoma in patients with cirrhosis. AJR Am J Roentgenol. 2008;190:47-57. [PMID: 18094293 DOI: 10.2214/ajr.07.2595] [Cited by in Crossref: 39] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
88 Kim JH, Kim MJ, Suh SH, Chung JJ, Yoo HS, Lee JT. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times. J Magn Reson Imaging 2002;15:573-83. [PMID: 11997899 DOI: 10.1002/jmri.10102] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
89 Outwater EK. Imaging of the liver for hepatocellular cancer. Cancer Control. 2010;17:72-82. [PMID: 20404790 DOI: 10.1177/107327481001700202] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
90 Lennerz JK, Crippin JS, Brunt EM. Diagnostic Considerations of Nodules in the Cirrhotic Liver: A Case-Based Perspective. Pathology Case Reviews 2009;14:3-12. [DOI: 10.1097/pcr.0b013e31819c4238] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
91 Bartolozzi C, Crocetti L, Lencioni R, Cioni D, Della Pina C, Campani D. Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media. Eur Radiol 2007;17:2519-30. [DOI: 10.1007/s00330-007-0602-5] [Cited by in Crossref: 68] [Cited by in F6Publishing: 53] [Article Influence: 4.5] [Reference Citation Analysis]
92 Nishie A, Tajima T, Ishigami K, Ushijima Y, Okamoto D, Hirakawa M, Nishihara Y, Taketomi A, Hatakenaka M, Irie H. Detection of hepatocellular carcinoma (HCC) using super paramagnetic iron oxide (SPIO)-enhanced MRI: Added value of diffusion-weighted imaging (DWI). J Magn Reson Imaging. 2010;31:373-382. [PMID: 20099351 DOI: 10.1002/jmri.22059] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
93 Swift O, Vilar E, Farrington K. Unexplained inflammation in end‐stage kidney disease: Is the combination of enhanced gastrointestinal permeability and reticuloendothelial dysfunction its cause? Semin Dial 2019;32:417-23. [DOI: 10.1111/sdi.12810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
94 Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, Kamura T, Gabata T, Murakami T, Ito K. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Invest Radiol. 2010;45:133-141. [PMID: 20098330 DOI: 10.1097/rli.0b013e3181caea5b] [Cited by in Crossref: 164] [Cited by in F6Publishing: 53] [Article Influence: 13.7] [Reference Citation Analysis]
95 Kim JI, Lee JM, Choi JY, Kim YK, Kim SH, Lee JY, Han JK, Choi BI. The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver. Invest Radiol. 2008;43:202-210. [PMID: 18301317 DOI: 10.1097/rli.0b013e31815d6929] [Cited by in Crossref: 60] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
96 Kobayashi S, Matsui O, Kamura T, Yamamoto S, Yoneda N, Gabata T, Terayama N, Sanada J. Imaging of benign hypervascular hepatocellular nodules in alcoholic liver cirrhosis: differentiation from hypervascular hepatocellular carcinoma. J Comput Assist Tomogr. 2007;557-563. [PMID: 17882031 DOI: 10.1097/rct.0b013e3180305bfb] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
97 Kim YK, Kwak HS, Kim CS, Chung GH, Han YM, Lee JM. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT. Radiology 2006;238:531-41. [PMID: 16371577 DOI: 10.1148/radiol.2381042193] [Cited by in Crossref: 82] [Cited by in F6Publishing: 72] [Article Influence: 4.8] [Reference Citation Analysis]
98 Kamel IR, Liapi E, Fishman EK. Liver and Biliary System: Evaluation by Multidetector CT. Radiologic Clinics of North America 2005;43:977-97. [DOI: 10.1016/j.rcl.2005.07.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
99 Chen R, Lii J, Chou C, Chang T, Chen W, Li C, Tu H. T2-weighted and T1-weighted Dynamic Superparamagnetic Iron Oxide (Ferucarbotran) Enhanced MRI of Hepatocellular Carcinoma and Hyperplastic Nodules. Journal of the Formosan Medical Association 2008;107:798-805. [DOI: 10.1016/s0929-6646(08)60193-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
100 Chou CT, Chen RC, Chen WT, Lii JM. Percentage of signal intensity loss for characterisation of focal liver lesions in patients with chronic liver disease using ferucarbotran-enhanced MRI. Br J Radiol 2010;83:1023-8. [PMID: 20413445 DOI: 10.1259/bjr/21476692] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
101 Tanimoto A. Use of SPIOs for Clinical Liver Imaging. In: Bulte JW, Modo MM, editors. Nanoparticles in Biomedical Imaging. New York: Springer; 2008. pp. 41-61. [DOI: 10.1007/978-0-387-72027-2_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
102 Okada M, Imai Y, Kim T, Kogita S, Takamura M, Kumano S, Onishi H, Hori M, Fukuda K, Hayashi N. Comparison of enhancement patterns of histologically confirmed hepatocellular carcinoma between gadoxetate- and ferucarbotran-enhanced magnetic resonance imaging. J Magn Reson Imaging. 2010;32:903-913. [PMID: 20882621 DOI: 10.1002/jmri.22333] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
103 Yu JS, Lee JH, Park MS, Kim KW. Hyperintense nodules on non-enhanced T1-weighted gradient-echo magnetic resonance imaging of cirrhotic liver: fate and clinical implications. J Magn Reson Imaging. 2006;24:630-636. [PMID: 16888794 DOI: 10.1002/jmri.20674] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
104 Tanaka H, Iijima H, Nouso K, Aoki N, Iwai T, Takashima T, Sakai Y, Aizawa N, Iwata K, Ikeda N, Iwata Y, Enomoto H, Saito M, Imanishi H, Nishiguchi S. Cost-effectiveness analysis on the surveillance for hepatocellular carcinoma in liver cirrhosis patients using contrast-enhanced ultrasonography: Cost-effectiveness of CEUS surveillance for HCC. Hepatology Research 2012;42:376-84. [DOI: 10.1111/j.1872-034x.2011.00936.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
105 Watanabe R, Matsumura M, Munemasa T, Fujimaki M, Suematsu M. Mechanism of hepatic parenchyma-specific contrast of microbubble-based contrast agent for ultrasonography: microscopic studies in rat liver. Invest Radiol. 2007;42:643-651. [PMID: 17700280 DOI: 10.1097/rli.0b013e31805f2682] [Cited by in Crossref: 79] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
106 Savić R, He X, Fiel I, Schuchman EH. Recombinant human acid sphingomyelinase as an adjuvant to sorafenib treatment of experimental liver cancer. PLoS One 2013;8:e65620. [PMID: 23724146 DOI: 10.1371/journal.pone.0065620] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
107 Martin DR, Semelka RC. IMAGING OF BENIGN AND MALIGNANT FOCAL LIVER LESIONS. Magnetic Resonance Imaging Clinics of North America 2001;9:785-802. [DOI: 10.1016/s1064-9689(21)00274-9] [Cited by in Crossref: 15] [Article Influence: 0.7] [Reference Citation Analysis]
108 Guiu B, Loffroy R, Ben Salem D, Lepage C, Guiu S, Aho S, Jouve JL, Krausé D, Cercueil JP. Combined SPIO-gadolinium magnetic resonance imaging in cirrhotic patients: negative predictive value and role in screening for hepatocellular carcinoma. Abdom Imaging 2008;33:520-8. [PMID: 17912584 DOI: 10.1007/s00261-007-9327-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
109 Kim SR, Imoto S, Nakajima T, Ando K, Mita K, Fukuda K, Nishikawa R, Koma YI, Matsuoka T, Kudo M, Hayashi Y. Utility of Gd-EOB-DTPA-Enhanced MRI in Diagnosing Small Hepatocellular Carcinoma. Case Rep Gastroenterol 2009;3:187-92. [PMID: 21103273 DOI: 10.1159/000226608] [Reference Citation Analysis]
110 Nguyen TDT, Pitchaimani A, Ferrel C, Thakkar R, Aryal S. Nano-confinement-driven enhanced magnetic relaxivity of SPIONs for targeted tumor bioimaging. Nanoscale 2018;10:284-94. [DOI: 10.1039/c7nr07035g] [Cited by in Crossref: 24] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
111 Tahir B, Sandrasegaran K, Ramaswamy R, Bertrand K, Mhapsekar R, Akisik FM, Saxena R. Does the hepatocellular phase of gadobenate dimeglumine help to differentiate hepatocellular carcinoma in cirrhotic patients according to histological grade? Clin Radiol 2011;66:845-52. [PMID: 21771548 DOI: 10.1016/j.crad.2011.03.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
112 Mandai M, Koda M, Matono T, Nagahara T, Sugihara T, Ueki M, Ohyama K, Murawaki Y. Assessment of hepatocellular carcinoma by contrast-enhanced ultrasound with perfluorobutane microbubbles: comparison with dynamic CT. Br J Radiol. 2011;84:499-507. [PMID: 20959373 DOI: 10.1259/bjr/38682601] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
113 Hennedige T, Venkatesh SK. Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring. Cancer Imaging. 2013;12:530-547. [PMID: 23400006 DOI: 10.1102/1470-7330.2012.0044] [Cited by in Crossref: 86] [Cited by in F6Publishing: 70] [Article Influence: 9.6] [Reference Citation Analysis]
114 Ma HL, Xu YF, Qi XR, Maitani Y, Nagai T. Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers. Int J Pharm. 2008;354:217-226. [PMID: 18191350 DOI: 10.1016/j.ijpharm.2007.11.036] [Cited by in Crossref: 83] [Cited by in F6Publishing: 68] [Article Influence: 5.5] [Reference Citation Analysis]
115 Lee DH, Kim SH, Lee JM, Park HS, Lee JY, Yi NJ, Suh KS, Jang JJ, Han JK, Choi BI. Diagnostic performance of multidetector row computed tomography, superparamagnetic iron oxide-enhanced magnetic resonance imaging, and dual-contrast magnetic resonance imaging in predicting the appropriateness of a transplant recipient based on milan criteria: correlation with histopathological findings. Invest Radiol 2009;44:311-21. [PMID: 19462486 DOI: 10.1097/rli.0b013e31819c9f44] [Cited by in Crossref: 32] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
116 Kudo M. Multistep human hepatocarcinogenesis: correlation of imaging with pathology. J Gastroenterol. 2009;44 Suppl 19:112-118. [PMID: 19148804 DOI: 10.1007/s00535-008-2274-6] [Cited by in Crossref: 148] [Cited by in F6Publishing: 144] [Article Influence: 11.4] [Reference Citation Analysis]
117 Celli N, Gaiani S, Piscaglia F, Zironi G, Camaggi V, Leoni S, Righini R, Bolondi L. Characterization of liver lesions by real-time contrast-enhanced ultrasonography. Eur J Gastroenterol Hepatol. 2007;19:3-14. [PMID: 17206071 DOI: 10.1097/01.meg.0000250585.53608.3c] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
118 Tanabe M, Ito K, Shimizu A, Fujita T, Onoda H, Yamatogi S, Washida Y, Matsunaga N. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity. Magnetic Resonance Imaging 2009;27:801-6. [DOI: 10.1016/j.mri.2008.11.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
119 Tokunaga S, Koda M, Matono T, Sugihara T, Nagahara T, Ueki M, Murawaki Y, Kakite S, Yamashita E. Assessment of ablative margin by MRI with ferucarbotran in radiofrequency ablation for liver cancer: comparison with enhanced CT. Br J Radiol 2012;85:745-52. [PMID: 21385915 DOI: 10.1259/bjr/64518148] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
120 Kim SH, Lim HK, Choi D, Lee WJ, Kim SH, Kim MJ, Kim CK, Jeon YH, Lee JM, Rhim H. Percutaneous radiofrequency ablation of hepatocellular carcinoma: effect of histologic grade on therapeutic results. AJR Am J Roentgenol. 2006;186:S327-S333. [PMID: 16632696 DOI: 10.2214/ajr.05.0350] [Cited by in Crossref: 45] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
121 Koda M, Tokunaga S, Fujise Y, Kato J, Matono T, Sugihara T, Nagahara T, Ueki M, Murawaki Y, Kakite S. Assessment of ablative margin after radiofrequency ablation for hepatocellular carcinoma; comparison between magnetic resonance imaging with ferucarbotran and enhanced CT with iodized oil deposition. Eur J Radiol. 2012;81:1400-1404. [PMID: 21440397 DOI: 10.1016/j.ejrad.2011.03.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
122 Suzuki K, Okuda Y, Ota M, Kojima F, Horimoto M. Diagnosis of Hepatocellular Carcinoma Nodules in Patients With Chronic Liver Disease Using Contrast-Enhanced Sonography: Usefulness of the Combination of Arterial- and Kupffer-Phase Enhancement Patterns. Journal of Ultrasound in Medicine 2015;34:423-33. [DOI: 10.7863/ultra.34.3.423] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
123 Kudo M, Okanoue T. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology. 2007;72 Suppl 1:2-15. [PMID: 18087177 DOI: 10.1159/000111702] [Cited by in Crossref: 136] [Cited by in F6Publishing: 122] [Article Influence: 9.1] [Reference Citation Analysis]
124 Mori K, Fukuda K, Asaoka H, Ueda T, Kunimatsu A, Okamoto Y, Nasu K, Fukunaga K, Morishita Y, Minami M. Radiofrequency ablation of the liver: determination of ablative margin at MR imaging with impaired clearance of ferucarbotran--feasibility study. Radiology. 2009;251:557-565. [PMID: 19251941 DOI: 10.1148/radiol.2512081161] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
125 Arita J, Hasegawa K, Takahashi M, Hata S, Shindoh J, Sugawara Y, Kokudo N. Correlation Between Contrast-Enhanced Intraoperative Ultrasound Using Sonazoid and Histologic Grade of Resected Hepatocellular Carcinoma. American Journal of Roentgenology 2011;196:1314-21. [DOI: 10.2214/ajr.10.4310] [Cited by in Crossref: 34] [Cited by in F6Publishing: 13] [Article Influence: 3.1] [Reference Citation Analysis]
126 Murakami T, Hori M, Kim T, Hashimoto K, Dono K, Hayashi S, Sugihara E, Nagano H, Sase S, Sakon M, Monden M, Nakamura H. Xenon-Inhalation Computed Tomography for Noninvasive Quantitative Measurement of Tissue Blood Flow in Hepatocellular Carcinoma. Investigative Radiology 2004;39:210-5. [DOI: 10.1097/01.rli.0000119147.62137.fd] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
127 Tanaka Y, Nakazawa T, Inoue T, Yamane K, Kubota K, Uojima H, Takada J, Okuwaki Y, Hidaka H, Shibuya A, Kokubu S, Matsunaga K, Koizumi W. Superparamagnetic iron oxide-enhanced magnetic resonance imaging is useful in predicting malignant potential of vascular transformation of hypointense hypovascular nodules on gadoxetic acid-enhanced magnetic resonance imaging. Hepatol Res 2017;47:1118-26. [PMID: 27943555 DOI: 10.1111/hepr.12850] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
128 Gandhi SN, Brown MA, Wong JG, Aguirre DA, Sirlin CB. MR contrast agents for liver imaging: what, when, how. Radiographics. 2006;26:1621-1636. [PMID: 17102040 DOI: 10.1148/rg.266065014] [Cited by in Crossref: 103] [Cited by in F6Publishing: 83] [Article Influence: 6.4] [Reference Citation Analysis]
129 Jensen J, Chandra R. Theory of nonexponential NMR signal decay in liver with iron overload or superparamagnetic iron oxide particles. Magn Reson Med 2002;47:1131-8. [DOI: 10.1002/mrm.10170] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 2.4] [Reference Citation Analysis]
130 Han JK, Eun HW, Kim SH. [Radiologic findings of dysplastic nodule]. Korean J Hepatol 2008;14:231-4. [PMID: 18617772 DOI: 10.3350/kjhep.2008.14.2.231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
131 Cheng WZ, Zeng MS, Yan FH, Rao SX, Shen JZ, Chen CZ, Zhang SJ, Shi WB. Ferucarbotran versus Gd-DTPA-enhanced MR imaging in the detection of focal hepatic lesions. World J Gastroenterol 2007; 13(36): 4891-4896 [PMID: 17828821 DOI: 10.3748/wjg.v13.i36.4891] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
132 Tada T, Kumada T, Toyoda H, Sone Y, Kaneoka Y, Maeda A, Okuda S, Otobe K, Tsuji N. Utility of combined gray-scale and perflubutane contrast-enhanced ultrasound for diagnosing early hepatocellular carcinomas: Comparison of well differentiated and distinctly nodular types. Hepatol Res 2016;46:1214-25. [PMID: 26860925 DOI: 10.1111/hepr.12670] [Reference Citation Analysis]
133 Hussain SM, Semelka RC, Mitchell DG. MR imaging of hepatocellular carcinoma. Magn Reson Imaging Clin N Am. 2002;10:31-52, v. [PMID: 11998574 DOI: 10.1016/s1064-9689(03)00048-5] [Cited by in Crossref: 80] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
134 Toyoda H, Kumada T, Osaki Y, Oka H, Urano F, Kudo M, Matsunaga T. Staging hepatocellular carcinoma by a novel scoring system (BALAD score) based on serum markers. Clin Gastroenterol Hepatol. 2006;4:1528-1536. [PMID: 17162244 DOI: 10.1016/j.cgh.2006.09.021] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 3.4] [Reference Citation Analysis]
135 Kamel IR, Liapi E, Fishman EK. Multidetector CT of hepatocellular carcinoma. Best Practice & Research Clinical Gastroenterology 2005;19:63-89. [DOI: 10.1016/j.bpg.2004.10.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
136 Brix G, Kolem H, Nitz WR, Bock M, Huppertz A, Zech CJ, Dietrich O. Basics of Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy. In: Reiser MF, Semmler W, Hricak H, editors. Magnetic Resonance Tomography. Berlin: Springer Berlin Heidelberg; 2008. pp. 3-167. [DOI: 10.1007/978-3-540-29355-2_2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
137 Kwak HS, Lee JM, Kim YK, Lee YH, Kim CS. Detection of hepatocellular carcinoma: comparison of ferumoxides-enhanced and gadolinium-enhanced dynamic three-dimensional volume interpolated breath-hold MR imaging. Eur Radiol 2005;15:140-7. [PMID: 15449000 DOI: 10.1007/s00330-004-2508-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
138 Kang BK, Lim JH, Kim SH, Choi D, Lim HK, Lee WJ, Lee SJ. Preoperative depiction of hepatocellular carcinoma: ferumoxides-enhanced MR imaging versus triple-phase helical CT. Radiology. 2003;226:79-85. [PMID: 12511672 DOI: 10.1148/radiol.2261011827] [Cited by in Crossref: 73] [Cited by in F6Publishing: 54] [Article Influence: 3.8] [Reference Citation Analysis]
139 Nishie A, Yoshimitsu K, Nakayama T, Hatakenaka M, Irie H, Shioyama Y, Matsuura S, Nishihara Y, Kobayashi K, Honda H. In vitro imaging of human monocytic cellular activity using superparamagnetic iron oxide. Computerized Medical Imaging and Graphics 2007;31:638-42. [DOI: 10.1016/j.compmedimag.2007.07.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
140 Kumano S, Murakami T, Kim T, Hori M, Okada A, Sugiura T, Noguchi Y, Kawata S, Tomoda K, Nakamura H. Using superparamagnetic iron oxide-enhanced MRI to differentiate metastatic hepatic tumors and nonsolid benign lesions. AJR Am J Roentgenol 2003;181:1335-9. [PMID: 14573430 DOI: 10.2214/ajr.181.5.1811335] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
141 Mori K, Scheidler J, Helmberger T, Holzknecht N, Schauer R, Schirren CA, Bittmann I, Dugas M, Reiser M. Detection of malignant hepatic lesions before orthotopic liver transplantation: accuracy of ferumoxides-enhanced MR imaging. AJR Am J Roentgenol. 2002;179:1045-1051. [PMID: 12239063 DOI: 10.2214/ajr.179.4.1791045] [Cited by in Crossref: 31] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
142 Mitsunori Y, Tanaka S, Nakamura N, Ban D, Irie T, Noguchi N, Kudo A, Iijima H, Arii S. Contrast-enhanced intraoperative ultrasound for hepatocellular carcinoma: high sensitivity of diagnosis and therapeutic impact. J Hepatobiliary Pancreat Sci 2013;20:234-42. [PMID: 22399158 DOI: 10.1007/s00534-012-0507-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
143 . Chapter 2: Diagnosis and surveillance: Chapter 2: Diagnosis and surveillance. Hepatology Research 2010;40:16-47. [DOI: 10.1111/j.1872-034x.2010.00655.x] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
144 Takahashi M, Maruyama H, Ishibashi H, Yoshikawa M, Yokosuka O. Contrast-Enhanced Ultrasound With Perflubutane Microbubble Agent: Evaluation of Differentiation of Hepatocellular Carcinoma. American Journal of Roentgenology 2011;196:W123-31. [DOI: 10.2214/ajr.10.4242] [Cited by in Crossref: 35] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]